Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
Lazow, MA; Hoffman, L; Schafer, A; Osorio, DS; Boué, DR; Rush, S; Wright, E; Lane, A; DeWire-Schottmiller, MD; Smolarek, T; et al.
Acta Neuropathologica Communications.
2020;
8.
Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor.
Lazow, MA; Lawson, SA; Salloum, R; Hummel, TR; Pillay Smiley, N; DeWire-Schottmiller, MD; Fouladi, M; de Blank, P.
Journal of Pediatric Hematology/Oncology.
2020;
Publish Ahead of Print.
Variation in Platelet Delta Granules Over Time in Young Women Undergoing Evaluation for Heavy Menstrual Bleeding.
Woods, GM; Pillay Smiley, N; Stanek, J; Kahwash, S; Kerlin, BA; O’Brien, SH.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
2019;
22:123-127.
Introduction to the Special Issue on Pediatric Neuro-Oncology.
Pillay Smiley, N; Khatua, S.
Bioengineering.
2018;
5:109-109.
Primary Central Nervous System Malignant Melanoma in Children: A Case Series and Review of the Literature.
Choi, DK; Pillay-Smiley, N; Marzec, S; Wadhwani, NR; DiPatri, AJ; Tomita, T; Lulla, RR.
Journal of Pediatric Hematology/Oncology.
2018;
40:616-619.
Neurocognitive and Psychosocial Outcomes in Pediatric Brain Tumor Survivors.
Stavinoha, PL; Askins, MA; Powell, SK; Pillay Smiley, N; Robert, RS.
Bioengineering.
2018;
5:73-73.
Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.
Marini, BL; Benitez, LL; Zureick, AH; Salloum, R; Gauthier, AC; Brown, J; Wu, Y; Robinson, DR; Kumar, C; Lonigro, R; et al.
Translational Research: the journal of laboratory and clinical medicine.
2017;
188:27.e1-39.
Hypoxia-induced proliferation of HeLa cells depends on epidermal growth factor receptor-mediated arginase II induction.
Setty, BA; Pillay Smiley, N; Pool, CM; Jin, Y; Liu, Y; Nelin, LD.
Physiological Reports.
2017;
5:e13175-e13175.
Severe Radiation Necrosis Successfully Treated With Bevacizumab in an Infant with Low-Grade Glioma and Tumor-Associated Intractable Trigeminal Neuralgia.
Pillay Smiley, N; Alden, T; Hartsell, W; Fangusaro, J.
Pediatric Blood and Cancer.
2016;
63:1671-1673.